The results showed that RS was closely related to KRAS signaling up, EMT and other pathways related to cancer development and metastasis, and the immune-related pathways IL6 JAK STAT3 signaling and IL2 STAT5 signaling were significantly different in patients with high and low RS (Fig. 13B). The gene discussed is STAT3; the disease is cancer.